Volitionrx (VNRX) Shares Outstanding (Diluted Average) (2013 - 2025)

Volitionrx (VNRX) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $106.8 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 23.46% year-over-year to $106.8 million; the trailing twelve-month figure through Dec 2025 stood at $106.8 million (up 23.46% YoY), and the FY2025 full-year result was $106.8 million, up 23.46% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $106.8 million, down from $108.2 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $108.2 million in Q3 2025 and bottomed at $71.2 million in Q4 2023.
• The 3-year median for Shares Outstanding (Diluted Average) is $86.5 million (2024), against an average of $91.2 million.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 28.57% in 2025, while the deepest fall reached 17.79% in 2025.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $71.2 million in 2023, then rose by 21.47% to $86.5 million in 2024, then rose by 23.46% to $106.8 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $106.8 million (Q4 2025), $108.2 million (Q3 2025), and $102.7 million (Q2 2025), per Business Quant data.

Peer Comparison